Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ASMB

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Assembly Biosciences Inc

ASMB
Current price
18.68 USD -0.82 USD (-4.21%)
Last closed 19.30 USD
ISIN US0453962070
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 147 404 704 USD
Yield for 12 month +24.20 %
1Y
3Y
5Y
10Y
15Y
ASMB
21.11.2021 - 28.11.2021

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Address: Two Tower Place, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30.00 USD

P/E Ratio

Dividend Yield

Financials ASMB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+28 520 000 USD

Last Year

+7 163 000 USD

Current Quarter

+9 419 000 USD

Last Quarter

+7 357 000 USD

Current Year

+28 391 000 USD

Last Year

-41 737 000 USD

Current Quarter

+9 419 000 USD

Last Quarter

+7 325 000 USD
EBITDA -44 502 000 USD
Operating Margin TTM -105.54 %
Price to Earnings
Return On Assets TTM -25.49 %
PEG Ratio
Return On Equity TTM -133.65 %
Wall Street Target Price 30.00 USD
Revenue TTM 32 154 000 USD
Book Value 3.56 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 62.80 %
Dividend Yield
Gross Profit TTM -26 751 000 USD
Earnings per share -6.20 USD
Diluted Eps TTM -6.20 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -124.15 %

Stock Valuation ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.69
Price Sales TTM 4.58
Enterprise Value EBITDA 0.42
Price Book MRQ 5.25

Technical Indicators ASMB

For 52 Weeks

7.75 USD 19.93 USD
50 Day MA 15.56 USD
Shares Short Prior Month 16 578
200 Day MA 14.37 USD
Short Ratio 0.92
Shares Short 30 615
Short Percent 0.31 %